BioTech Startup

Dimension Secures $500M to Fund Biotech-Tech Convergence

Dimension, a biotech venture firm founded by former Lux Capital and Obvious Ventures investors, has raised its second fund, Dimension II, which totals $500 million, surpassing the $350 million...

BioTech Startup

Biotech Nintx Secures US$ 10 Million To Develop Medicines From Brazilian Biodiversity

Nintx (Next Innovative Therapeutics), a biotech company focused on developing treatments for multifactorial diseases using Brazil’s biodiversity, has raised an additional US$ 10 million following a US$ 3 million...